ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Clinical outcomes of a cohort of 271 patients with lung metastases from differentiated thyroid carcinoma

Maciel, Joana*; Cavaco, Daniela; Silvestre, Catarina; Pereira, Joana Simoes; Vilar, Helena; Leite, Valeriano
Clinical Endocrinology2022-12DOI: 10.1111/cen.14700
3被引4阅读
引用收藏
分享

摘要

Context Lung is the most common site of distant metastases from differentiated thyroid carcinoma (DTC). Objective To investigate the outcomes of a cohort of patients with DTC and lung metastases (LM). Methods A retrospective analysis of a cohort of 271 patients with LM was performed. Results The female-to-male ratio was 1:1 and the median follow-up time was 5.9 (1.1-38.4) years. Papillary thyroid carcinoma (PTC) was the most frequent type (83.4%), mainly the classic variant, followed by follicular thyroid carcinoma (FTC, 10.3%) and Hurthle cell carcinoma (HTC, 6.3%). The prevalence of PTC, FTC and HCC was different between the micronodular and macronodular LM groups [87.4%, 6.3% and 6.3% vs. 74.6%, 19.0% and 6.3%, respectively (p = .013)]. Only 5.0% of the patients had LM diagnosed after a period of remission. LM were submitted to radioactive iodine treatment (RAIT) in 84.5% (52.8% showed (131)iodine avid metastases). Complete remission was only achieved in 12.2%. Micronodular disease and age <55 years at LM diagnosis were associated with a better prognosis (p < .05). We found no difference in survival between patients with LM treated or not with RAIT. However, in patients submitted to RAIT, there was a tendency for longer survival in the group of patients with I-131 avid lesions. Conclusion: The classic variant of PTC was the most frequent histology found in LM of DTC. LM are rarely diagnosed in the follow-up when complete remission is achieved after surgery and I-131. Younger age at LM diagnosis and a micronodular pattern are associated with a better prognosis.

学科与关键词

关键词
advanced thyroid cancerdifferentiated thyroid carcinomadistant metastasesfollicular thyroid carcinomalung metastasespapillary thyroid carcinomathyroid carcinoma
相关
加载中…
  • Long-Term Prognosis of Differentiated Thyroid Cancer with Lung Metastasis in Korea and Its Prognostic Factors
    Cho, Sun Wook; Choi, Hoon Sung; Yeom, Gye Jeong; Lim, Jung Ah; Moon, Jae Hoon; Park, Do Joon; Chung, June-Key; Cho, Bo Youn; Yi, Ka Hee; Park, Young Joo*Thyroid : official journal of the American Thyroid Association , 2014, 24(2): 277-286.被引 79
  • Locoregional progression-free survival of bone metastases from differentiated thyroid cancer
    Luo, Jiaxin; Yin, Weili; Lin, Qiuxia; Wu, Juqing; Chen, Pan; Ling, Yuanna; Wang, Jing; Li, Zhen; Pan, Liqin; Chen, Yanying; Ouyang, Wei*; Feng, Huijuan*Endocrine Connections, 2022, 11(3): e220042.被引 1
  • Possible delayed diagnosis and treatment of metastatic differentiated thyroid cancer by adopting the 2015 ATA guidelines
    Albano, Domenico*; Bertagna, Francesco; Bonacina, Mattia; Durmo, Rexhep; Cerudelli, Elisabetta; Gazzilli, Maria; Panarotto, Maria Beatrice; Formenti, Anna Maria; Mazziotti, Gherardo; Giustina, Andrea; Giubbini, RaffaeleEuropean Journal of Endocrinology, 2018, 179(3): 143-151.被引 35
查看全部 →

发表信息

论文状态
公开发表
期刊
Clinical Endocrinology
发表日期
2022-12
卷期
第 97 卷, 第 6 期
页码
814-821
DOI
10.1111/cen.14700
语言
ENGLISH
期刊等级
2区
成果收录
SCIE

作者

  • M

    Maciel, Joana (通讯) (第一作者)

  • C

    Cavaco, Daniela

查看全部 6 位作者收起作者
  • S

    Silvestre, Catarina

  • P

    Pereira, Joana Simoes

  • V

    Vilar, Helena

  • L

    Leite, Valeriano

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417